Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
27%(3 trials)

Phase Distribution

Ph phase_4
8
57%
Ph phase_2
1
7%
Ph not_applicable
4
29%
Ph phase_3
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
8(57.1%)
N/ANon-phased studies
4(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
Not yet recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.1%)
Phase 31 (7.1%)
Phase 48 (57.1%)
N/A4 (28.6%)

Trials by Status

not_yet_recruiting17%
unknown17%
completed1179%
withdrawn17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT07048886Phase 4

Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)

Not Yet Recruiting
NCT00607776Phase 2

Artificial Tears Study in Mild to Moderate Dry Eye Patients

Completed
NCT01650584Not Applicable

Evaluation of Ocular Comfort With ISTA Tears vs Systane

Completed
NCT00565669Not Applicable

Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms

Completed
NCT01657253Phase 3

Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye

Completed
NCT00812721Not Applicable

Tears Substitutions and Their Effects on Higher Order Aberrometery

Withdrawn
NCT01386073Phase 4

Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity

Unknown
NCT01160133Not Applicable

To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops

Completed
NCT01311609Phase 4

A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients

Completed
NCT00724412Phase 4

Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye

Completed
NCT00818909Phase 4

Systane Clinical Experience Study

Completed
NCT00622037Phase 4

Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

Completed
NCT00620893Phase 4

Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).

Completed
NCT00627302Phase 4

Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14